MedTech News
.................... by Andrew Celentano
FDA expands approval of Instylla’s Embrace HES for arterial bleeds
Data supporting the expanded clearance came from the HALT study involving 130 patients.
Mezoo: The Wonju Wearable Taking Patient Monitoring Beyond the Bedside
Mezoo has turned a credit-card-sized chest patch into a monitoring platform used in more than 700 Korean hospitals and clinics.
Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).
First patient undergoes pioneering stem-cell treatment for Parkinson’s
A patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker behind the treatment said on Friday, in a world first following its conditional approval in the country.
Cancer-promoting proteins may make tumors easier to spot… but also help them evade immune attack
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.
New swab test could spare some women a painful biopsy for endometrial cancer
A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.
Magnetic bead implants could offer more accurate way to control prosthetic limbs
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with certain types of amputations to control their prosthetic limbs.
CereVasc Receives FDA IDE Approval to Evaluate the eShunt® System in Patients with Alzheimer’s Disease
FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer’s disease